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Dermatitis herpetiformis (D H) is characterized in part by an 
associated gluten-sensitive enteropathy (GSE), and a strong 
association with the HLA antigens HLA-Al, -B8, -DR3, and 
-DQw2, essentially identical to that seen in patients with 
isolated GSE (celiac disease). A 4.0-kb Rsai RFLP has been 
identified using a DQ /]-chain eDNA and localized to the 
HLA-DP /]-chain region. This RFLP has been found more 
frequently in patients with isolated GSE than in normal HLA 
matched controls. We have analyzed genomic DNA from 24 
patients with DH and 15 HLA-matched controls to deter-
mine if this 4.0-kb Rsal RFLP was present in patients with 
DH. Twenty-one of 24 (87%) of patients with DH were 
found to have this RFLP as compared to 7 of 10 (70%) 
HLA-DR3, -DQw2 matched control subjects (p = 0.23). 
Thus, the 4.0-kb Rsai RFLP detected in patients with iso-
lated GSE is also present in patients with DH; however, its 
frequency in DH patients does not differ significantly from 
D ennatitis herpetiformis (DH) is a chronic, blistering skin disease that is characterized in part by the pres-ence of IgA deposits at the dermal- epidermal junc-tion, and an associated, often asymptomatic, gluten-sensitive enteropathy (GSE) (1,2]. Patients with DH 
also have been found to have an increased frequency of the HLA 
antigens HLA-Al, -B8, -DR3, and -_DQw2, similar to that seen in 
patients with isolated GSE (cellae disease) [3-14}. Although 80-
90% of patients with DH express HLA-Al and HLA-B8 (normal 
subjects: HLA-Al, 24%; HLA-B8, 21 o/o), in ~o.th patients with DH 
and with isolated GSE an even stronger assoctatlon has been demon-
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that of HLA matched controls. Family studies of patient~ 
with DH revealed that although the 4.0-kb Rsai RFLP segre\ 
gated with the HLA-Al, -B8, -DR3, -DQw2 haplotype ~ 
one family_, it did not segregate with this disease-associate~ 
haplotype 111 two other families . In both patient and contra( 
populations, this RFLP was associated with HLA-DPw1 o~ 
-DPw3 phenotypes; 25 of 26 (96%) HLA-DPwl or -DPwj 
subjects were found to have this RFLP compared to only 1 o~ 
6 (17%) who did not express HLA-DPwl or -DPw3 (pc"" 
0.0009). These population and family data suggest that this 
4.0-kb Rsai RFLP is primarily associated with the HLA, 
DPwl, -DPw3 phenotype, rather than the clinical manifes, 
tations o~D_H. These data further document that the strong, 
est assoClatwn of DH with HLA antigens remains wit~ 
HLA-DQw2 and HLA-DR3 antigens. J Invest Dermatol 
95:172-177, 1990 
strated with the HLA class II antigens HLA-DR3 and HLA-DQw 
(DH: HLA-DR3, 95%; HLA-DQw2, 100%; normal subjects\ 
HLA-DR3, 23%; HLA-DQw2, 40%) (4,6-8,11] . Further analysi\ 
of these HLA associations has demonstrated that the increased Ere\ 
quency of the HLA class I antigens, A1 and B8, in patients with D}i 
is primarily due to the strong positive linkage disequilibrium be, 
tween HLA-Al and -B8 and the HLA class II antigens HLA-DR 
and HLA-DQw2. Finally, analysis of a third region of expressed, 
HLA class II genes, HLA-DP, has revealed no statistically signifi, 
cant increase in HLA-DP antigen frequency in patients with DH, 
compared to HLA-DR3, -DQw2 matched control subjects [7], 
T aken together, these data suggest that the HLA-DR and HLA-D~ 
regions, specifically HLA-DR3 and -DQw2, are most important il.\ 
the pathogenesis ofDH (4,7,8]. 
Although the clinical features of patients with DH and those with 
isolated GSE are readily distinguishable, the HLA antigen Ere, 
quency of occurrence of the HLA-A1, -B8, -DR3, and -DQw 
antigens is almost identical in these two groups of patients [4,5,7), 
Patients with isolated GSE have been reported to have a highe~ 
frequency of a 4.0-kb restriction fragment length polymorphislll, 
(RFLP) at the HLA-DP ,8-chain gene locus than normal HLA-DR3 
control subjects (15). In order to determine whether this 4.0-kb 
RFLP might provide a means of genetically distinguishing between 
patients with isolated GSE and those with DH, we analyzed ge-
nomic DNA of patients with DH to determine if the 4.0-kb HLA-
DPP region RFLP is present more frequently in patients with DH 
than in HLA-DR3, -DQw2 control subjects. In addition, we have 
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studied families of patients with DH to determine if this 4.0-kb Rsal 
RFLP segregates with the clinical manifestations of DH and the 
HLA-Al, -B8, -DR3, -DQw2 haplotype associated with DH. Fi-
nally, we have correlated the presence of this RFLP with HLA 
phenotype to determine if this 4.0-kb Rsal RFLP may be related to a 
particular HLA phenotype. 
MATERIALS AND METHODS 
Patient and Control Cell Lines Twenty-four patients with 
d~;rmatitis herpetiformis were studied. All patients had typical clini-
cal and histologic features of DH; and direct immunofluorescence 
revealed granu lar deposits of IgA at the dermal- epidermal junction 
of perilesional skin. Ten unaffected fami ly members of five patients 
with DH were also studied. The HLA type of18 of the DH patients 
and of all family members was determined as previously described 
for HLA class I antigens A and Band the HLA class II antigens DR, 
DQ, and DP [7]. The remaining six patients with DH were HLA-
types at the HLA-A, -B, -DR, and -DQ loci as previously described 
[16]. Lymphoblastoid cell lines were established for all DH patients 
and all family members by culturing 2 X 106 peripheral blood 
mononuclear cells with the supernatant from the Epstein-Barr 
virus (EBV) producing cell line B95-8 in the presence of Cyclospor-
ine A (2 J.lg/ml). The established B cell lines were maintained in 
RPMI-1 640 with 0.1 mM nonessential amino acids, 2 mM gluta-
mine, 1 mM pyruvate, 2 X 10-3 ujml insulin, and 20% heat-inacti-
vated fetal calf serum. 
EBV-transformed cell lines from 10 HLA-DR3 and -DQw2 con-
trols were studied as were five HLA-DP-typed control cell lines 
(ASHI Repository, Boston, MA). 
DNA Purification Genomic DNA was prepared by incubating 
50 X 106 of the EBV -transformed B cel ls at 55 • C in 2 ml of a buffer 
containing 50 mM Tris-HCl , 100 mM NaCl , 1 mM EDTA, 0.5% 
SDS, and 0.1 mg/ml proteinase-K, pH 7.5, for 16 h. The solution 
was then extracted two times with Tris-HCI saturated phenol, fol-
lowed by two extractions with chloroform/isoamyl alcohol (24: 1, 
v: v). The solution was dialyzed against 10 mM Tris-HCl, 1 mM 
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EDTA, pH 7.4 (TE) . After dialysis one ninth the total volume of 3 
M sodium acetate was added, followed by absolute ethanol 2.5 times 
the aqueous volume at- 20 •c. After incubation for 1 hat- 20 •c, 
the precipitated DNA was washed in 70% ethanol, and resuspended 
in TE buffer. 
RFLP Analysis Ten micrograms of genomic DNA from pa-
tients, family members, and controls was digested for 4 h at 37 °C 
with 50 U of the restriction endonuclease Rsai (Bethesda Research 
Laboratories, Gaithersburg, MD), according to the manufacturer's 
specifications. After digestion, the reaction was terminated by heat-
ing at 7o•c for 5 min. The digested DNA was then separated by 
electrophoresis in a 0.8% agarose gel in 40 mM Tris/acetate, 1 mM 
EDTA, pH 7.8 buffer [17]. After electrophoresis, the DNA was 
denatured by washing the gel 30 min in a 0.5 M NaOH, 1.5 M 
NaCI buffer followed by three washes of 20 min each in a 0.025 M 
NaH2P04 , 0.025 M Na2HP04 , 0.7 H20 buffer. The DNA was 
then transferred to Gene-screen plus (New England Nuclear, Wil-
mington, DE), as described by Southern, using ·10 X SSC (1 X 
SSC = 150 mM sodium chloride, 15 mM sodium citrate, pH 7.4) 
for 16 h [17,18]. After transfer the Gene-screen plus was allowed to 
air dry and then was prehybridized for 6 h at 42 •c in a buffer 
containing 50% deionized formamide, 10% dextran sulfate, 0.2% 
bovine serum albumin, 0.2% polyvinylpyrrolidone, 0.2% ficoll, 50 
mM Tris, 0.1% sodium pyrophosphate, 1% SDS, and 100 J.lg/ml 
denatured salmon sperm DNA (Sigma Chemical, St. Louis, MO). 
The eDNA probe used for hybridization was a full-length eDNA 
encoding a DQ/3 chain (pii fJ-1) (provided by Dr. Per Peterson, 
(Scripps Research Foundation, La Jolla, CA) [19]. The probe was 
radiolabeled by the method of Feinberg and Vogelstein [20] and 
hybridization conducted overnight at 42 • C after addition of32P-la-
beled probe to the prehybridization buffer to a final concentration of 
1- 2 X 106 cpm/ml. After hybridization, the filters were washed 
two times at room temperature in 2 X SSC for 5 min each, followed 
by two washes in 2 X SSC with 1% SDS at 62•c for 30 min each, 
fo ll owed by two washes in 0.1 X SSC at room temperature for 30 
min each. The filters were then exposed to Kodak X-OMAT AR 
x-ray fi lm with intensifying screens for 2-4 d. 
H LA-D Region 4.0 Kilobase RFLP 
Figure 1. Southern blot analysis of Rsal digest of ge-
nomic DNA from eight patients with dermatitis herpet-
iformis and five control subjects, using the DQ fl-chain 
eDNA probe pll fl-1. The 4.0-kb RFLP (arrows) is seen 
in three of five control subjects and seven of eight pa-
tients with DH. Numbering of patients and controls 
corresponds to Table I. 
Controls 
2 3 4 5 
Dermatitis Herpetiformis 
23kb 
9.5 kb 
4.0kb----
2.0kb 
2345678 
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RESULTS 
RFLP Analysis DNA from 24 patients with DH was digested 
with the restriction enzyme Rsal and analyzed for the presence of a 
4.0-kb RFLP using the DQ /3-chain eDNA (pll /J-1). Twenty-one 
of 24 (87%) patients with DH were found to have this 4.0-kb Rsal 
RFLP as compared to 7 of 10 (70%) HLA-DR3, -DQw2 control 
subjects (Fig 1) (Table I) (p = 0 .23, Fisher's exact test). These data 
demonstrate that this 4.0-kb Rsal RFLP, although, present in most 
patients with DH, is not specific for DH since it is also frequently 
present in the HLA matched (HLA-DR3, -DQw2) control popula-
tion. Although this RFLP is not specific for DH, it may represent 
another marker of the HLA haplotype thought to be important in 
DH (HLA-A1 , -B8, -DR3, -DQwZ). 
In order to determine if this RFLP segregates with the haplotype 
thought to play a role in the pathogenesis of DH (i.e., HLA-A1, 
-BB, -DR3, -DQw2, "DH haplotype"), five families containing 10 
unaffected first-degree relatives and five patients with DH were 
analyzed for the presence of the 4.0-kb Rsal RFLP (Fig 2). The 
4.0-kb RFLP was found in all five families studied; however, the 
data from two of these families (families 4 and 5, Table II) were not 
informative regarding the linkage of this 4.0-kb Rsal RFLP and the 
HLA-A1, -B8, -DR3, -0Qw2 haplotype. 
Table I. Patient and Control Population 
Presence 
of 4.0-kb 
HLA-DPw HLA-DQw HLA-DR Rsal RFLP 
Patients 
1 NO• 2b 3,7 + 
2 ND 1,2 1,3 + 
3 1,4 2,3 3,4 + 
4 3,4 2,3 3,5 
5 1,4 1,2 3,6 + 
6 2,3 2,3 3,5 + 
7 1,4 2,3 3,4 + 
8 4 1,2 2,3 + 
9 2,4 2,3 3,4 
10 1,2 1,2 3,6 + 
11 3,4 1,2 2,3 + 
12 1,4 2 3,7 + 
13 1,3 1,2 3,6 + 
14 1,3 2 3 + 
15 2,3 2 3,7 + 
16 3 2 3,8 + 
17 2 2 3,7 
18 2,3 2 3,7 + 
19 3,4 1,2 4,6 + 
20 3 2 3,8 + 
21 ND 2 3,7 + 
22 ND 1,2 3,6 + 
23 ND 2 3,7 + 
24 ND 2,3 5,7 + 
Controls 
1 ND 2 3,7 + 
2 ND 2,3 3,12 + 
3 ND 2,2 3,3 
4 ND 1,2 2,3 
5 ND 1,2 3,14 + 
6 ND 2,2 3,7 
7 ND 2,6 3,7 + 
8 ND 2,3 3,4 + 
9 ND 2 3,7 + 
10 ND 1 3,8 + 
11 3,3 5,5 16,16 + 
12 3,3 7,7 11,11 + 
13 3,3 6,6 13,13 + 
14 1,1 5,5 1 '1 + 
15 1,1 6,6 13,13 + 
•ND =Not done. 
'HLA antigen. 
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FAMILY 1 
0 0 
• HLA Haplotype a b c d a c 
DPw 2 4 4 3 2 4 
DQw 3 3 /- 2 3 3 2 
DR 4 8 3 4 4 3 
RFLP + 
FAMILY 2 
0 0 
• HLA Haplotype a b c d a c 
DPw 2 3 4 2 
DQw 21- 2/- 2 1 2/- 2 
DR 7 3 2 7 3 
RFLP + 
FAMILY 3 
0 0 
• HLA Haplotype a b c d a c 
DPw 4 4/- 4 4 
DQw 1 1/- 2 1 2 
DR 6 6/- 3 6 3 
RFLP + + 
Figure 2. Family studies in patients with dermatitis herpetiform is showin 
the segregation of the 4.0-kb Rsal RFLP with HLA haplotypes. The 4.0-k~ 
Rsal RF~P se_gregates with the HLA-DPw1 or -DPw3 phenotype and no\ 
necessarily w1th the haplotype most often associated with DH (HLA-A! 
-B8, -DR3, -DQw2) . Family numbers correspond to those shown in Tabl~ 
II. 
In the remaining families, the RFLP data were informative. I~ 
one family (family 3, Table II), the RFLP did segregate with th~ 
HLA-A1 , -B8, -DR3, -DQw2 haplotype. In the remaining fami1 
lies, however, this was not confirmed. In two families (families 1 
and 2, Table II), the RFLP was not present in the patient with DH 
but rather was detected in an unaffected parent and did not segrega~ 
with the HLA-Al, -B8, -DR3, -DQw2 haplotype. This data dem1 
onstrates that the 4.0-kb Rsai is not in a strong positive-linkag~ 
disequilibrium with either the HLA-A1, -B8, -DR3, -0Qw2 hap, 
lotype or the clinical manifestations of DH. This conclusion · 
further supported by the fact that an unaffected sibling of the patien1 
in fami ly 5 was also found to have the RFLP without any clini 
evidence of DH and without having the HLA-A1, -B8, -DR 1 
-0Qw2 haplotype. Thus, although this RFLP may often be present 
in patients with DH, it is not highly associated with either th~ 
clinical martifestations of the disease or the HLA-Al, -BB, -DR3, 
-0Qw2 haplotype; and, therefore, is most likely not directly relat 
to the pathogenesis of the disease. 
In the three families where the RFLP could be assigned to an 
HLA haplotype (families 1, 2, and 3, Table II), the RFLP segregat . 
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Table II. Family Studies of Patients with Dermatitis Herpetiformis 
Family Relation Haplotype DPw DQw DR B A 4.0-kb RFLP 
Patient a 2' 3 4 44 2 
cb 4 2 3 8 1 
Father a 2 3 4 44 2 
b 4 3/- 8 44/- 3 
Mother cb 4 2 3 8 1 
d 3 3 4 35 3 + 
2 
Patient a 2 2/- 7 14 11 
cb 2 3 8 1 
Father a 2 2/- 7 14 11 
b 3 2/- 7/ - 27 2 + 
Mother cb 2 3 8 1 
d 4 1 2 62 2 
3 
Patient a 4 1 6 39 2 
cb 1 2 3 8 1 + 
Father a 4 1 6 39 2 
b 4/ - 1/ - 6/- 27 28 
Mother cb 1 2 3 8 1 + 
d 4 1 1 35 3 
4 
Patient a 2 2/- 7 8 2 +/ -
cb 3 2 3 8 1 (+} 
Father a 2 2/- 7 8 2 +/-
b 4 2/- 3 so 11 +/-
Mother cb 3 2 3 8 1 (+) 
d 4 3 4 62 2 (+) 
5 
Patient d· 1 2 3 8 1 (+) 
a 3 l 6 40 24 (+} 
Sister b 4 2 7 62 2 (+) 
d 3 3 4 35 31 (+) 
Mother cb 1 2 3 8 1 (+) 
d 3 3 4 35 31 (+) 
• HLA antige n. 
• Haplotype-presumed to encode disease gene{s) due to expression ofHLA-A 1, -B8, -DR3, -DQw2;- = undefined allele; x/ - = uncertainty whether the haplotype expresses the 
al lele "x" or an undefined allele; + j - = indeterminate presence of RFLP; ( +) = RFLP present, bur could not be assigned to specific haplotype. 
with the HLA-DPw1 or -DPw3 phenotype and not necessari ly 
with HLA-DR3 or -DQw2. To determine whether this RFLP 
might be associated with HLA-DPw1 and/or -DPw3, 3 homozy-
gous HLA-DPw3 cell lines and 2 homozygous HLA-DPw1 cell 
lines (none of which expressed either HLA-DR3 or -DQw2) were 
analyzed for the presence of the 4.0-kb Rsai RFLP. In all five of 
these cell lines, the 4.0-kb Rsal RFLP was detected (Table I), sup-
porting the hypothesis that this 4.0-kb Rsal RFLP may be associated 
with HLA-DPw1 and -DPw3. Analysis of all subjects (patients, 
unaffected family members, and controls) revealed that the 4.0-kb 
Rsai RFLP was present in 25 of 26 (96%) HLA-DPw1 or -DPw3 
subjects, but in only 1 of 6 (17%) subjects who did not express 
HLA-DPw1 or -DPw3 (pc = 0.0009, two-tailed Fisher's exact test 
corrected for 5 HLA-DP alleles tested for) . 
DISCUSSION 
The distinctiveness of the clinical features of DH and isolated GSE 
suggests that each disease may have unique genetic characteristics 
that would separate patients with DH from those with isolated GSE. 
In general, however, it has appeared to date that patients with these 
two related, yet distinctive, diseases have a similar HLA phenotype 
(5- 7,9-10,12 - 14). Recently, Howell and co-workers described a 
4.0-kb Rsai RFLP using a DQP-chain eDNA probe, Pllfi1 [15,21) . 
They detected this RFLP in 95% of patients with isolated GSE and 
in only 27% of normal HLA-DR3/DQw2 controls [15,21). 
In order to determine if this 4.0-kb Rsai RFLP was also present in 
patients with DH, we have analyzed genomic DNA from 24 pa-
tients with DH using Rsai and the same DQ P-chain eDNA probe 
used by Howell et al (15). We have found that 87% of our patients 
with DH have the 4.0-kb RFLP, which Howell eta! found in 95% 
of their patients with isolated GSE. Since the major HLA association 
that is found in .patients with DH is with HLA-DR3, -DQw2, we 
have examined 10 normal HLA-DR3, -DQw2 subjects for this 
RFLP and found that 7 of 10 (70%) HLA-DR3/DQw2 control 
subjects also had this 4.0-kb Rsai RFLP. Similar results have also 
been reported by Sacks and co-workers, who analyzed genomic 
DNA from patients with isolated GSE and normal HLA-DR3, 
-DQw2 control subjects and found no difference in the bands seen 
using Rsai and the eDNA DQ P-chain probe pll P-1 (22). Our data 
document that the 4.0-kb Rsai RFLP found in patients with isolated 
GSE is also present in most patients with DH, further demonstrat-
ing the genetic similarity between patients with isolated GSE and 
patients with DH. However, much like the association of the 
HLA-A1 and HLA-B8 antigens in DH, the high frequency of this 
RFLP in normal HLA-DR3/ DQw2 subjects suggests that this 
RFLP is not specific for either DH or isolated GSE, but rather may 
be a secondary assoCiation with either HLA-DR3, -DQw2, or other 
associated HLA antigens. 
Although this 4.0-kb Rsai RFLP does not appear to be specific for 
either DH or isolated GSE, it could be strongly associated with the 
HLA-A1 , -B8, -DR3, -DQw2 haplotype. One method of examin-
ing this question is to study families of patients with DH. If in the 
family studies the RFLP cosegregates with the clinical disease and 
the HLA-Al, -B8, -DR3, -DQw2 haplotype, it is more likely that 
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the RFLP and the disease are genetically linked. We have studied 
the families of5 patients with DH for the presence of this RFLP. In 
three of the families, the RFLP could be assigned to a specific HLA 
haplotype (families 1, 2, and 3, Table II). In one instance, the 4.0-kb 
RFLP was present on the haplotype thought to be of primary im-
portance in DH (i.e., the haplotype containing HLA-DR3 and 
-DQw2); however, in the other two families the RFLP did not 
segregate with this haplotype or with the clinical manifestations of 
the disease. In the remaining two families, the. RFLP was also 
present in family members without the disease, including an unaf-
fected sister (family 5), as well as in the patients with DH. These 
data document that this 4.0-kb Rsal RFLP is not predictive of either 
the clinical manifestations of DH or the HLA-Al, -B8, -DR3, 
-DQw2 haplotype, and suggests that the chromosomal region 
where this RFLP is found does not play a primary role in the patho-
genesis of DH. 
Howell and co-workers have localized this 4.0-kb Rsal RFLP to 
the region of the HLA-DP fJ-chain gene on chromosome 6 [15,21). 
Recently, we have investigated the frequency ofHLA-DP antigens, 
a third locus of expressed HLA class-II genes, in patients with DH 
(7]. Although both HLA-DPw1 and HLA-DPw3 were present 
more frequently in patients with DH (HLA-DPw1, 44%; HLA-
DPw3, 32%) than in HLA-DR3 control subjects (HLA-DPw1, 
26%; HLA-DPw3, 13%), this difference was not statistically signif-
icant when corrected for the number of alleles examined [7). These 
data suggest that the positive association seen with HLA-DP anti-
gens in patients with DH is, like_ the associatio~ with tl_1e clas~-I 
antigens HLA-A1 and -B8, most likely due to a lrnkage dtsequthb-
rium with the HLA class-II antigens, HLA-DR3 and -DQw2 [7). 
We hypothesized at that time that the 4.0-kb Rsal RFLP found in 
isolated GSE may be associated with the HLA-DPwl and/or HLA-
0Pw3 phenotypes. Recently, Kagnoff et a! reported that patients 
with isolated GSE have an increased frequency of both HLA-DPw1 
and HLA-0Pw3, similar to that reported for patients with DH (23). 
In addition, they reported that the presence of the 4.0-kb Rsal DP-/3 
RFLP in patients with isolated GSE could be accounted for by the 
increased frequency of HLA-DPw1 and/or -DPw3 [23]. 
We have also investigated the relationship of this RFLP to HLA-
DP phenotype in our patients and normal subjects who have been 
HLA-DP-typed (18 patients with DH, 9 nonaffected family mem-
bers, and 5 non-HLA-DR3, -0Qw2 normal subjects). Analysis of 
these 32 HLA-DP-typed subjects for the 4.0-kb Rsal RFLP revealed 
a significant association with HLA-DPwl and/or HLA-DPw3 phe-
notype (two-tailed Fisher's exact test, p = 0.00017, uncorrected; 
p = 0.0009 corrected for five DP alleles tested for). Indeed, anal_ysis 
of three cell lines homozygous for HLA-DPw3 and two cellltnes 
homozygous for HLA-DPw1 revealed that even though none of 
these lines expressed either HLA-DR3 or -0Qw2 all of the five cell 
Jines were found to have the 4.0-kb Rsal RFLP. These data suggest 
that the 4.0-kb Rsal RFLP present in patients with DH is related to 
HLA-DP phenotype and not primarily associated with_ DH. Analy-
sis of the family studies further supports tillS findmg 111 that when 
the 4.0-kb Rsal RFLP could be assigned to a haplotype, it was 
associated with the HLA-DPw1 and/or -0Pw3 containing haplo-
type. 
We have found that 87% of patients with DH have a 4.0-kb 
RFLP using Rsal and the DQ fJ-chain eDNA pll /3~ 1_, similar ~o the 
frequency of this RFLP in isolated GSE. In addttton, stud1es ~f 
HLA-DP-typed patients, families, and controls suggest that this 
4.0-kb Rsal RFLP is not restricted to the haplotype thought to be 
important in the pathogenesis of DH (HLA-A1, -B8, -DR3, 
-DQw2), but rather its presence is related to the increased frequency 
of HLA-DPwl and HLA-0Pw3 in patients with DH. These data 
are in agreement with that reported by Kagnoff et al for patients 
with isolated GSE [23), and provide further documentation of the 
genetic similarity between patients with_DH a~d with isolated GSE. 
Recent evidence from a number of mvesugators has suggested 
that isolated GSE is primarily associated with HLA-DQ region 
genes [9,24,25). Our data suggest th~t this HLA region is also _of 
primary importance in the pathogenesis ofDH. The lack of a statts-
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tically significant association with HLA-DPw1 or HLA-DPw3 a11, 
tigens and DH, and the lack of tight genetic linkage between D~ 
and the 4.0-kb Rsal DP fJ-chain region RFLP, suggest that the "D~ 
haplotype" may not extend to the more centromeric HLA-DP r~ 
gion. These data also document the close similarity of the HL,\ 
class-II phenor_yl?e of patients _w~th D~ and is?late_d GSE_, and su~, 
gest that the cluu~al charactenstlcs wh1ch dlStmglll~h patients wi~ 
DH from those w1th Isolated GSE cannot yet be attnbuted to diffe~ 
ences in HL~ phenotype. [t is possible, however, that molecul' 
charactenzatton of the HLA-DQ locus may reveal important diffe~ 
ences between patients with DH and those with isolated GS' 
which may relate to the clinical differences observed. 
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